Abstract:BACKGROUND: Axillary vein puncture (AVP) and cephalic vein surgical cutdown are recommended in international guidelines because of their low risk of pneumothorax and chronic lead complications. Directly visualizing and puncturing the axillary vein under ultrasound guidance reduces radiation exposure, provides direct needle visualization, and lowers periprocedural complications. Our hypothesis is that ultrasound-guided axillary access is safer and more feasible than the standard fluoroscopic technique.OBJECTIVES: The purpose of this study was to assess the efficacy and safety of ultrasound-guided axillary venous access during cardiac lead implantation for pacemakers (PMs) and implantable cardioverter-defibrillator (ICD) implantations.METHODS: Patients were randomized in a 1:1 fashion to either axillary venous access under fluoroscopic guidance or ultrasound-guided axillary venous access. The composite outcome, including pneumothorax, hemothorax, inadvertent arterial puncture, pocket hematoma, pocket infection, lead dislodgement, and death, was evaluated 30 days after implantation.RESULTS: We randomized 270 patients into 2 groups: the standard group for fluoroguided AVP (n = 134) and the experimental group for ultrasound-guided AVP (n = 136). No disparities in baseline characteristics were observed between the groups. The median age of the patients was 81 years, with women comprising 41% of the population. The majority of patients received single- and dual-chamber PMs (87% vs 88%; P = 1.00), and slightly over 10% in both groups received ICDs (13% vs 12%; P = 0.85). In total, we placed 357 leads in PMs and 48 leads in ICDs. Among these, 295 leads were inserted via axillary vein access and 110 via cephalic vein access. Notably, the subclavian vein was never used as a vascular access. The composite outcome was lower in the ultrasound group according to intention-to-treat analysis (OR: 0.55; 95% CI: 0.31-0.99; P = 0.034). The main difference within the composite outcome was the lower incidence of inadvertent axillary arterial puncture in the experimental group (17% vs 6%; P = 0.004). The ultrasound group also exhibited lower total procedural x-ray exposure (10,344 μGy × cm<sup>2</sup> vs 7,119 μGy × cm<sup>2</sup>; P = 0.002) while achieving the same rate of success at the first attempt (61% vs 69%; P = 0.375).CONCLUSIONS: Ultrasound-guided AVP is safer than the fluoroscopy-guided approach because it achieves the same rate of acute success while maintaining low total procedural radiation exposure. Ultrasound AVP should be considered the optimal venous access method for cardiac lead implantation. (Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation [ZEROFLUOROAXI]; NCT05101720).

Prevalence of venous occlusion in patients referred for lead extraction: implications for tool selection.

Risk factors for severe complications of transvenous lead extraction

Re-evaluation of Transvenous Lead Extraction with Modified Standard Technique: a Prospective Study in 229 Patients.

Incidence of Venous Thromboembolism and Hemorrhage in Chinese Patients after Pulmonary Lobectomy: Mechanical Prophylaxis or Mechanical Prophylaxis Combined with Pharmacological Prophylaxis: a Randomized Controlled Trial.

Preliminary Clinical Experience of Transveneous Extraction in Patients with Cardiovascular Implantable Electronic Device Infection

Preoperative and Intraoperative Imaging during Transvenous Lead Extraction

Snare Sheath Versus Evolution Sheath In Transvenous Lead Extraction

Safety and efficacy of combined dilation/stenting of venous abnormalities, including complete obstructions, during lead extractions in patients with congenital heart disease

A Large Single-Center Clinical Trial of Transvenous Lead Extraction

Indications and outcomes of elective open chest lead extractions

Lead Management in Special Scenarios

Out with the old: Single center experience with transvenous extraction of leads older than 15 years

Efficacy and Safety of Transvenous Lead Extraction in the Chinese Octogenarian Patients

Ultrasound-Guided Venous Axillary Access Versus Standard Fluoroscopic Technique for Cardiac Lead Implantation

Predictors for Adverse Events During Cardiac Lead Extraction - Experience from a Large Single Centre.

When and how to perform venoplasty for lead placement

Cardiac tamponade as an inherent but potentially nonfatal complication of transvenous lead extraction: Experience with 1126 procedures performed using mechanical tools

VDD Lead Extraction—Differences with Other Leads and Practical Tips in Management

What Important Information Does Transesophageal Echocardiography Provide When Performed before Transvenous Lead Extraction?

Comparison of Management for Central Venous Stenosis With or Without Previous Catheter Placement

The Clinical Role of Transesophageal Echocardiography During Transvenous Lead Extraction.